Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Haihe Biopharma Co. Ltd. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 3 examiners and 3 art units, indicating distinct examination assignments.
RZECZYCKI, PHILLIP MATTHEW is the busiest examiner, with 1 pending matter. No examiner has a larger recorded allocation, so counsel should use application-specific tracking and response strategies.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RZECZYCKI, PHILLIP MATTHEW | 1 | 64.8% | +37.0% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18707240 | SOLID DISPERSION, PREPARATION METHOD THEREFOR, AND SOLID FORMULATION CONTAINING SAME | WILLIS, DOUGLAS M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730623 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | RZECZYCKI, PHILLIP MATTHEW | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730623 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | RZECZYCKI, PHILLIP MATTHEW | — |
| 18707240 | SOLID DISPERSION, PREPARATION METHOD THEREFOR, AND SOLID FORMULATION CONTAINING SAME | WILLIS, DOUGLAS M | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18730623 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | RZECZYCKI, PHILLIP MATTHEW | 1625 | §103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18707240 | SOLID DISPERSION, PREPARATION METHOD THEREFOR, AND SOLID FORMULATION CONTAINING SAME | WILLIS, DOUGLAS M | 1624 | §112Other | Non-Final OA | — | Pending | May 03, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHaihe Biopharma Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Phillip Matthew Rzeczycki has the most, with 1 of Haihe Biopharma Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
